197 related articles for article (PubMed ID: 34627251)
1. Distinct clinical features and prognostic factors of hepatitis C virus-associated non-Hodgkin's lymphoma: a systematic review and meta-analysis.
Zhang M; Gao F; Peng L; Shen L; Zhao P; Ni B; Hou J; Huang H
Cancer Cell Int; 2021 Oct; 21(1):524. PubMed ID: 34627251
[TBL] [Abstract][Full Text] [Related]
2. Inferior survival and frequent hepatic dysfunction in non-Hodgkin's lymphoma patients with HBV infection: a systematic review and meta-analysis.
Zhang MY; Gao F; Zhao YW; Ni BW; Huang HH; Hou J
Hematology; 2022 Dec; 27(1):70-79. PubMed ID: 34957924
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of tumour-associated macrophages in Non-Hodgkin's lymphoma: A systematic review and meta-analysis.
Xu X; Li Z; Liu J; Zhu F; Wang Z; Wang J; Zhang J; Wang H; Zhai Z
Scand J Immunol; 2020 Jan; 91(1):e12814. PubMed ID: 31419843
[TBL] [Abstract][Full Text] [Related]
4. [Meta analysis of whether cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy can improve survival in patients with colorectal cancer peritoneal metastasis].
Liu D; Wang H; Yuan ZX; Chen WW; Wu ZJ; Liu XX; Luo J; Chu LL; Li Y; Cai J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):256-263. PubMed ID: 34645170
[No Abstract] [Full Text] [Related]
5. [Efficacy and safety of rituximab in children and adolescents with mature B-cell non-Hodgkin's lymphoma: a Meta analysis].
Li BY; Han YH; Yin CY; DU WC; Li YF; Wang YC
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jan; 25(1):51-59. PubMed ID: 36655664
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of new direct antiviral agents in hepatitis C virus-infected patients with diffuse large B-cell non-Hodgkin's lymphoma.
Persico M; Aglitti A; Caruso R; De Renzo A; Selleri C; Califano C; Abenavoli L; Federico A; Masarone M
Hepatology; 2018 Jan; 67(1):48-55. PubMed ID: 28714143
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis.
Gisbert JP; García-Buey L; Pajares JM; Moreno-Otero R
Gastroenterology; 2003 Dec; 125(6):1723-32. PubMed ID: 14724825
[TBL] [Abstract][Full Text] [Related]
8. HCV infection, B-cell non-Hodgkin's lymphoma and immunochemotherapy: Evidence and open questions.
Cox MC; Aloe-Spiriti MA; Cavalieri E; Alma E; Gigante E; Begini P; Rebecchini C; Delle Fave G; Marignani M
World J Gastrointest Oncol; 2012 Mar; 4(3):46-53. PubMed ID: 22468183
[TBL] [Abstract][Full Text] [Related]
9. Concurrent infection of hepatitis B virus negatively affects the clinical outcome and prognosis of patients with non-Hodgkin's lymphoma after chemotherapy.
Chen J; Wang J; Yang J; Zhang W; Song X; Chen L
PLoS One; 2013; 8(7):e69400. PubMed ID: 23861969
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of survivin in patients with non-Hodgkin's lymphoma: a meta-analysis.
He C; Liu Z; Ji J; Zhu H
Int J Clin Exp Med; 2015; 8(4):5847-54. PubMed ID: 26131175
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Role of EGFR/p-EGFR in Patients With Nasopharyngeal Carcinoma: A Meta-Analysis.
Chen X; Liang R; Lai L; Chen K; Zhu X
Front Oncol; 2021; 11():697369. PubMed ID: 34490092
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma.
Mizorogi F; Hiramoto J; Nozato A; Takekuma Y; Nagayama K; Tanaka T; Takagi K
Intern Med; 2000 Feb; 39(2):112-7. PubMed ID: 10732826
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus infection prevalence and liver dysfunction in a cohort of B-cell non-Hodgkin's lymphoma patients treated with immunochemotherapy.
Nosotti L; D'Andrea M; Pitidis A; Pimpinelli F; Dessanti ML; Pisani F; Vignally P; Petti MC
Scand J Infect Dis; 2012 Jan; 44(1):70-3. PubMed ID: 21905952
[TBL] [Abstract][Full Text] [Related]
14. The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis.
Peveling-Oberhag J; Arcaini L; Bankov K; Zeuzem S; Herrmann E
J Viral Hepat; 2016 Jul; 23(7):536-44. PubMed ID: 26924533
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular adverse events associated with cyclophosphamide, pegylated liposomal doxorubicin, vincristine, and prednisone with or without rituximab ((R)-CDOP) in non-Hodgkin's lymphoma: A systematic review and meta-analysis.
Lu B; Shen L; Ma Y; Qi J; Li Y; Wang Z; Han L; Zhong M
Front Pharmacol; 2022; 13():1060668. PubMed ID: 36532720
[No Abstract] [Full Text] [Related]
16. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus - associated B cell non-Hodgkin's lymphoma.
Mihăilă RG
World J Gastroenterol; 2016 Jul; 22(27):6214-23. PubMed ID: 27468211
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus infection and non-hepatocellular malignancies in the DAA era: A systematic review and meta-analysis.
Masarone M; Persico M
Liver Int; 2019 Jul; 39(7):1292-1306. PubMed ID: 30983083
[TBL] [Abstract][Full Text] [Related]
19. A Meta-Analysis on the Relationship Between Hair Dye and the Incidence of Non-Hodgkin's Lymphoma.
Qin L; Deng HY; Chen SJ; Wei W
Med Princ Pract; 2019; 28(3):222-230. PubMed ID: 30583293
[TBL] [Abstract][Full Text] [Related]
20. Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies.
Matsuo K; Kusano A; Sugumar A; Nakamura S; Tajima K; Mueller NE
Cancer Sci; 2004 Sep; 95(9):745-52. PubMed ID: 15471561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
